Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02987946Completed
Randomised, open-label trial (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Incidence of thromboembolic complications at 1 week. Started Dec 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02987946.